ICD-10-CM Billable Code

D89.2

Hypergammaglobulinemia, unspecified

Clinical Classification Guidelines

Medical Intelligence & Overview

Hypergammaglobulinemia is a condition characterized by an increased level of gamma globulins, a type of antibody, in the blood. These proteins are produced by plasma cells as part of the immune response. When their levels are elevated without a specified cause, the condition is termed hypergammaglobulinemia, unspecified. This condition can be associated with various underlying health issues, including infections, autoimmune diseases, and certain types of cancers. Recognizing the signs and understanding the potential causes can help in managing the condition effectively.

Causes & Symptoms

Clinical Causes: Chronic infections such as hepatitis, tuberculosis, or bacterial infections Autoimmune disorders like rheumatoid arthritis or lupus Multiple myeloma or other plasma cell neoplasms Chronic liver diseases Other inflammatory or immune-related conditions

Key Symptoms: Often asymptomatic and discovered through blood tests Swelling or enlargement of lymph nodes Fatigue and weakness Unexplained weight loss Persistent fever or night sweats Symptoms related to other underlying conditions

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves blood tests that measure immunoglobulin levels, including serum protein electrophoresis to detect abnormal gamma globulin levels. Doctors may also perform additional tests such as blood counts, imaging studies, or biopsies to identify the underlying cause. A thorough medical history and physical examination are essential components of the diagnostic process.

Treatment Protocols: Since hypergammaglobulinemia is often a sign of an underlying condition, treatment focuses on addressing that primary issue. Management strategies may include medications to control autoimmune activity, antibiotics for infections, or chemotherapy for related cancers. Regular monitoring of immunoglobulin levels and overall health is also important to assess the effectiveness of treatment and adjust as necessary.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D89.2 a billable ICD-10 code?
Yes, D89.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D89.2?
Clinical documentation must specify the nature of Hypergammaglobulinemia, unspecified and any associated comorbidities for accurate reporting.

Cite this Clinical Reference